Ligand-based targeted therapy for cancer tissue

Author： Das Manasi   Mohanty Chandana   Sahoo Sanjeeb K  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.6, Iss.3, 2009-03, pp. : 285-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

By Brumlik Michael J   Daniel Benjamin J   Waehler Reinhard   Curiel David T   Giles Francis J   Curiel Tyler J  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 1, 2008-01 ,pp. : 87-103

Informa Healthcare

Access to resources Recommend Favorite

Targeted nanotheranostics for personalized cancer therapy

By Diou Odile   Tsapis Nicolas   Fattal Elias  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 12, 2012-12 ,pp. : 1475-1487

Informa Healthcare

Access to resources Recommend Favorite

Cancer gene therapy with targeted adenoviruses

By Bachtarzi Houria   Stevenson Mark   Fisher Kerry  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 11, 2008-11 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Antibody-targeted liposomes in cancer therapy and imaging

By Sofou Stavroula   Sgouros George  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 2, 2008-02 ,pp. : 189-204

Informa Healthcare

Access to resources Recommend Favorite

Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy

By Simon Manuel   Stefan Nikolas   Plückthun Andreas   Zangemeister-Wittke Uwe  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 4, 2013-04 ,pp. : 451-468

Informa Healthcare

Access to resources Recommend Favorite